Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2023

Shareholders' Equity [Abstract]

Schedule of fair value assumptions

	2023 Grant
Valuation assumptions:
Dividend yield	0
Expected volatility	39%-48%
Risk-free interest rate	2%-4%%
Expected life (years) *	4.0
Vesting period (years)	1.0

*Expected life for the periods presented was determined according to the simplified method since the Company does not have enough history to make an estimate.

Schedule of stock option activity

	Year Ended December 31,
	2023					2022					2021
				Weighted					Weighted					Weighted
	Number			average		Number			average		Number			average
	of			exercise		of			exercise		of			exercise
	options			price US$		options			price US$		options			price US$
Outstanding at January 1		21,318			12.96		22,102			12.66		89,925			3.80
Granted		16,224			31.5		-			-		5,704			36.45
Forfeited and cancelled		-			-		-			-		(106	)		4.38
Exercised		(11,445	)		16.41		(784	)		4.38		(73,421	)		3.67
Outstanding at year end		26,097			22.99		21,318			12.96		22,102			12.66
Exercisable at year end		22,577			16.78		21,318			12.96		16,398			4.38

Schedule of options outstanding

			Weighted	Aggregate
	Number	Weighted	Average	intrinsic
	of	average	Remaining	Value (in
	options	exercise	Contractual	US$
	outstanding	price US$	term (years)	thousands)
Outstanding and exercisable as of December 31, 2023	22,577	16.67	3.73	1,189

Schedule of information about non-vested options

				Weighted
				average
				grant- date
	Options			fair value
Balance at January 1, 2023		-			-
Granted		16,224			12.32
Vested		(12,704	)		7.87
Forfeited		-			-
Balance at December 31, 2023		3,520			28.4

Schedule of restricted share unit activity

	RSUs		Weighted average grant date value
Balance at January 1, 2023	1,101,421		$	28.58
Granted	541,248		$	26.43
Vested	(477,235	)	$	24.56
Forfeited	(30,083	)	$	31.55
Balance at December 31, 2023	1,135,351		$	29.27